Global Non-Animal Softgel Capsules Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Global Non-Animal Softgel Capsules Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Non-Animal Softgel Capsules market size was valued at US$ 427 million in 2024 and is forecast to a readjusted size of USD 597 million by 2031 with a CAGR of 4.9% during review period.

Non-animal Softgel Capsules is a kind of Softgels, a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both. Non-animal Softgel Capsules are all-natural, GMO free, plant-based shell, free from animal derivatives, gluten, and modified sugars. Nowadays, Non-animal Softgel Capsules can be divided into several kinds such as Plant Polysaccharides (Pullulan), Starches, and Hydroxyl Propyl Methyl Celluloses. Non-animal Softgel Capsules possess the benefits of suited for Halal or Kosher certification; Pure, clear and elegant appearance with no taste or odor; Ideal for improving the bioavailability of oil soluble ingredients; Easy to swallow, safe, non-carcinogenic and tamper evident, etc.

Catalent, Procaps Laboratorios, Aenova, Bahrain Pharma, Robinson Pharma, etc. are the key vendors in the global vegetarian softgel capsules market. The top 5 took up more than 70% of the global market. Catalent, Procaps Laboratorios, Aenova, etc. which have leading technology and market position, are well-known vendors around the world. Americas is the largest region of vegetarian softgel capsules in the world, which takes up about 47% of the global revenue market, while Europe and the Asia Pacific were about 23%, 20% respectively. Vegetarian softgel capsules are mainly classified into the following types: plant polysaccharides and starch. Plant polysaccharides is the most widely used type which takes up about 75% of the total sales. This product also has a wide range of applications, such as health supplements, pharmaceuticals, etc. And health supplements sector was the most widely used area which accounts for over 75% of the global total, the application in pharmaceutical focuses on OTC products.

This report is a detailed and comprehensive analysis for global Non-Animal Softgel Capsules market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Non-Animal Softgel Capsules market size and forecasts, in consumption value ($ Million), sales quantity (M Capsules), and average selling prices (US$/Capsule), 2020-2031

Global Non-Animal Softgel Capsules market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Capsules), and average selling prices (US$/Capsule), 2020-2031

Global Non-Animal Softgel Capsules market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Capsules), and average selling prices (US$/Capsule), 2020-2031

Global Non-Animal Softgel Capsules market shares of main players, shipments in revenue ($ Million), sales quantity (M Capsules), and ASP (US$/Capsule), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Non-Animal Softgel Capsules

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Non-Animal Softgel Capsules market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Catalent, Procaps Laboratorios, EuroCaps, Baihe, Aenova, Captek, Sirio, Bahrain Pharma, Robinson Pharma, Aland, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Non-Animal Softgel Capsules market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Carrageenan Softgel
Starch Softgel
Gellan Gum Softgel

Market segment by Application
Health Supplements
Pharmaceutical
Others

Major players covered
Catalent
Procaps Laboratorios
EuroCaps
Baihe
Aenova
Captek
Sirio
Bahrain Pharma
Robinson Pharma
Aland
Fuji Capsule
Sunsho Pharmaceutical
Erkang

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Non-Animal Softgel Capsules product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Non-Animal Softgel Capsules, with price, sales quantity, revenue, and global market share of Non-Animal Softgel Capsules from 2020 to 2025.

Chapter 3, the Non-Animal Softgel Capsules competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Non-Animal Softgel Capsules breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Non-Animal Softgel Capsules market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Non-Animal Softgel Capsules.

Chapter 14 and 15, to describe Non-Animal Softgel Capsules sales channel, distributors, customers, research findings and conclusion.